Raphaela Freidl received the advancement award “Specific Immunotherapy” of the German Society of Allergology and Clinical Immunology
The advancement award “Specific Immunotherapy” sponsored by Allergopharma GmbH & Co. KG is awarded yearly at the annual meeting of the German Society of Allergology and Clinical Immunology (DGAKI) for outstanding original work.
Raphaela Freidl, MSc., received the award for the study „Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy”, published in the Journal of Allergy and Clinical Immunology (2017; 139(6):1897-1905).
The study was conducted under the supervision of Assoc. Prof. Dr. Birgit Linhart at the Institute of Pathophysiology and Allergy Research (Division of Immunopathology, Head: Rudolf Valenta).
back to: CePII